Chemical Structure (Duloxetine 01)
Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 68001-368
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 68001-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Duloxetine 02)
Figure 2 (Duloxetine 03)
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 7 (Duloxetine 06)
Figure 8 (Duloxetine 07)
Figure 9 (Duloxetine 08)
Duloxetine 09
This appears to be a chart or table showing the percentage of patients who experienced improvements in pain, with values ranging from 0 to 280. Without additional context or information, it is unclear what the units or specific measurements represent.*
Duloxetine 10
Duloxetine 14
This text contains medication information for Duloxetine Delayed-Release Capsules, USP. Each capsule contains 49 E-ispense and must be kept in a tightly closed container. The medication is manufactured by TOWA Pharmaceutical Europe, S.L. and is RxOnly, therefore it must be dispensed by a pharmacist. It is important to keep the medication out of reach of children and store it at 25°C (77°F). The text also includes the NDC code (68001-368-04) and an expiration date (022021). The rest of the text seems to be a mix of characters without any clear meaning.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
